Genetic tests for cancer can run thousands of dollars, but Color Genomics plans to change that: it's offering testing for the cancer risk variants BRCA1 and BRCA2 — as well as 17 others — for $249, ...
Pathway Genomics said that it has launched BRCATrue, a next- generation sequencing and deletion/duplication analysis that can detect mutations in BRCA1 and BRCA2, the genes linked to breast, ovarian ...
One year ago, Color Genomics — a genetic testing startup created by former Google and Twitter leaders Othman Laraki and Elad Gil, PhD — began sending risk tests for breast and ovarian cancer. Now it’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results